Zacks Investment Research
03 Jun 2026, 17:46 UTC · 2h ago
Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Search tags
Zacks Investment Research
03 Jun 2026, 17:46 UTC · 2h ago
Search tags
Story key points
3 claims · impact-rated
Electromed, Inc. (ELMD) is projected to achieve EPS growth of 41.2% this year, significantly exceeding the industry average of 10.5%. — Strongly positive earnings growth projections relative to peers typically drive stock price appreciation.
+0.60Electromed's year-over-year cash flow growth is 48.9%, compared to an industry average of -0.7%. — Substantial cash flow growth indicates strong operational health and the ability to fund expansion without external debt.
+0.50Electromed currently possesses a top Zacks Rank and a favorable Zacks Growth Style Score. — Positive analyst rankings can increase institutional and retail buying interest in a specific ticker.
+0.30Ticker attribution
Model heads
Continue reading
6 related stories
The company is recommended as a top growth pick with a top Zacks Rank and projected EPS growth significantly beating the industry average.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
1 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Zacks Investment Research
2h ago
